CEO selling following an earnings miss and pipeline delay is a cautionary signal, but the dollar amount is small relative to market cap. Monitor for additional insider sales in the next 2 weeks; if C-suite selling continues, it would reinforce the bearish read. The volixibat Phase 3 requirement and timeline, not insider trades, remain the primary catalyst for the stock.
MIRM drugs
MIRM drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 12 $98.97entry
- T+1 · 3mo ago −0.20%α −0.90% · $98.77
- T+5 · 3mo ago +3.30%α +3.75% · $102.24
- T+20 · 2mo ago +1.66%α +3.55% · $100.61
- T+60 · 12d ago −2.02%α +2.86% · $96.97
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Christopher Peetz executed a cluster of open-market sales totaling ~$1.98M, including a single-day sale of 11,683 shares at ~$1.15M, alongside derivative exercises. The sales follow a Q2 earnings miss and volixibat pipeline delay reported 6 days prior. While the dollar amount is modest relative to Mirum's $6.4B market cap (0.03%), the CEO's status amplifies the signal, particularly given the negative earnings surprise and pipeline setback disclosed in the same window.
Key Financial Metrics
Key Facts
- CEO Peetz sold ~$1.98M in open-market sales on 2026-08-10, the largest being 11,683 shares at ~$1.15M
- Total cluster value of ~$2.32M (including Jolanda Howe's $194K sale) represents ~0.04% of Mirum's $6.4B market cap
- Sales occurred 6 days after Q2 2026 earnings (GAAP EPS -$1.06 vs -$0.75 consensus) and a volixibat NDA delay to H1 2027
- Peetz also exercised 40,000 derivative shares (20,000 at $2.936; 20,000 at $0), these are non-cash events
- Prior insider activity (30d): 4 sells totaling $2.2M at higher prices, suggesting a selling pattern
Financial Impact
CEO open-market sales of ~$1.98M; cluster total ~$2.32M, 0.04% of market cap
Risk Factors
- Further insider sales could signal deteriorating management confidence
- Q2 EPS miss and volixibat delay already pressured sentiment; additional negative news could compound
- CEO derivative exercises (40,000 shares) will add to share count, though at minimal cost basis
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MIRM-1786485690367 |
Track record
27 reports on MIRM
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +28.29% at T+20 after the Jun 11, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 Now $91.58 −0.76% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 Now $91.58 −2.10% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 Now $91.58 −1.88% settles Feb 10
- Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 Now $91.58 −3.01% settles Feb 8
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 Now $91.58 −5.56% settles Feb 2
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 Now $91.58 +6.72% settles Jan 26
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 Now $91.58 +7.04% settles Jan 25
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 Now $91.58 +15.02% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers